Revvity (RVTY) cash on hand

Cash · fiscal 2025
$919.86M

Revvity (RVTY) held cash of $919.86M at the end of fiscal 2025 (December 31, 2025). That is 20.9% lower than the $1.16B of fiscal 2024. Figures as of 18 Nov 2026, 01:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$919.86M
Change on fiscal 2024
−20.9%
Highest on record
$1.60Bfiscal 2023
Lowest on record
$454.36Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Revvity cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $1.60B in fiscal 2023 and the lowest $454.36M in fiscal 2022.

History · 4 fiscal years

Cash by fiscal year

Revvity cash on hand, year by year

Revvity (RVTY) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$919.86M 20.9% down
2024$1.16B 27.4% down
2023$1.60B 252.8% up
2022$454.36M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Revvity and comparable companies
CompanyCashFiscal year
Medpace Holdings MEDP$497.05M2025
Revvity RVTY$919.86M2025
Exelixis EXEL$1.06B2025
Charles River Laboratories International CRL$213.77M2025
Neurocrine Biosciences NBIX$1.48B2025
Ascendis Pharma ASND€616.04M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RVTY

Revvity, figure by figure

Revvity (RVTY) overview: price, valuation and scorecardAll health care companies by market value

Revvity cash on hand: questions and answers

How much cash does Revvity have?

Revvity (RVTY) held cash of $919.86M at the end of fiscal 2025 (December 31, 2025). That is 20.9% lower than the $1.16B of fiscal 2024.

What are the highest and lowest cash figures on record for Revvity?

Across the 4 fiscal years on record (2022–2025), the highest was $1.60B in fiscal 2023 and the lowest $454.36M in fiscal 2022.

How is Revvity's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Revvity (RVTY) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/RVTY/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.